Bio-key International, Inc. (BKYI) Misses Q1 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BKYI Hot Sheet
Price: $2.31 -6.85%
EPS Growth %: -133.3%
Financial Fact:
Net income (loss): -1.13M
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: -133.3%
Financial Fact:
Net income (loss): -1.13M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Bio-key International, Inc. (NASDAQ: BKYI) reported Q1 EPS of ($0.16). Revenue for the quarter came in at $1.61 million.
For earnings history and earnings-related data on Bio-key International, Inc. (BKYI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- e.l.f. Beauty, Inc. (ELF) Tops Q2 EPS by 64c, Beats on Revenue; Offers FY27 Guidance
- Acadia Pharma (ACAD) Tops Q3 EPS by 11c, Beats on Revenue; Offers FY26 Revenue Guidance
- a.k.a. Brands Holding Corp. (AKA) Misses Q3 EPS by 37c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
